Clinical Trial Update: Immunogenicity and Safety of One Dose of HPV Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial updating on immunogenicity and safety of a single dose of an HPV vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Human Papillomavirus-related Diseases

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Xiamen Innovax Biotech Co., Ltd | Conditions: Human Papillomavirus Vaccines | Phase 4 | Status: COMPLETED